← Back to Search

Procedure

Arm 1-Repeat Cryoballoon Ablation for Atrial Fibrillation

N/A

Waitlist Available

Led By Advay Bhatt, MD

Research Sponsored by Valley Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up six months

Awards & highlights

Study Summary

This trial will compare cryoballoon ablation to radiofrequency ablation in people who have had cryoballoon ablation before for atrial fibrillation and now have it again.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PrimaryCryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm 2-Radiofrequency AblationExperimental Treatment1 Intervention

Participants will have radiofrequency ablation guided by high-fidelity mapping (Rhythmia) following an initial cryoballoon ablation.

Group II: Arm 1-Repeat Cryoballoon AblationExperimental Treatment1 Intervention

Subjects will be randomized to repeat cryoballoon ablation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Valley Health SystemLead Sponsor

9 Previous Clinical Trials

1,843 Total Patients Enrolled

4 Trials studying Atrial Fibrillation

565 Patients Enrolled for Atrial Fibrillation

Advay Bhatt, MDPrincipal InvestigatorThe Valley Hosptial

Media Library

Cryoballoon ablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03811795 — N/A

Atrial Fibrillation Research Study Groups: Arm 1-Repeat Cryoballoon Ablation, Arm 2-Radiofrequency Ablation

Atrial Fibrillation Clinical Trial 2023: Cryoballoon ablation Highlights & Side Effects. Trial Name: NCT03811795 — N/A

Cryoballoon ablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03811795 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To which demographic groups is this trial most applicable?

"This research requires 50 volunteers, aged 18 or above, who have been given a diagnosis of paroxysmal or persistent atrial fibrillation in accordance with the recent Heart Rhythm Society (HRS) guidelines."

Answered by AI

How many individuals are contributing data to this research endeavor?

"Indeed, the data posted on clinicaltrials.gov reveals that recruitment for this medical study is ongoing. This research was first published on November 27th 2018 and last updated March 29 2021; it seeks to enlist 50 patients from 3 distinct sites."

Answered by AI

Does this clinical trial permit individuals over the age of 25 to participate?

"This clinical trial is seeking applicants aged 18 to 100. In comparison, there are 11 studies available for minors and 474 trials targeted at geriatric individuals."

Answered by AI

Are individuals currently being enrolled for this experiment?

"Affirmative - The clinicaltrials.gov registry exhibits that this research is currently recruiting participants and was first published on November 27th 2018, before being revised for the last time on March 29th 2021. This trial seeks to enroll 50 patients from 3 distinct healthcare facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib

2018. "Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03811795.